NOS2 and Klebsiella Infections: TAU treatment also reduces the expression levels of markers such as inducible nitric oxide synthase (iNOS), nuclear factor kappa-B (NF-κB), TNF-α and IL-2 during acute inflammation and has been shown to reduce TNF-α, IL-1β and IL-6 levels in Klebsiella infections [19–22].